The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

Despite representing only 4% of the world’s population, the United States accounts for over half of science Nobel Prizes ...

The president of the European Union’s executive branch, Ursula von der Leyen, faces a no-confidence vote this week linked in ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

Sustainable change requires improved study design, market incentives, and patient involvement, write Kate Womersley and colleagues For too long, medical research has defaulted to male physiology, ...